RODEN MATTHEW 4
4 · iTeos Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
RODEN MATTHEW
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-17+16,608→ 0 totalExercise: $26.03Exp: 2031-06-17→ Common Stock (16,608 underlying)
Footnotes (1)
- [F1]This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders.